期刊文献+

不同周龄高血压大鼠肾小动脉结构变化与细胞外信号调节激酶1/2关系的研究 被引量:3

下载PDF
导出
摘要 目的:探讨高血压血管重构的特点及其机制。方法:采用组织病理学、组织化学和免疫组织化学方法,对比观察不同周龄自发性高血压大鼠肾小动脉形态学变化及细胞外信号调节激酶1/2(ERK1/2)磷酸化特点。结果:SHR16周龄和24周龄血压(分别为201±21mmHg和204±16 mmHg)明显高于4周龄和8周龄SHR组(P<0.01)。对照组和SHR4及8周龄组肾小动脉结构未见异常。SHR16周龄组少数小动脉管壁可见增厚。SHR24周龄组可见个别小叶间动脉细胞数目增多,并可见弓形动脉和小叶间动脉有内弹力膜增厚、分离及断裂现象。免疫组化结果显示,SHR16周龄、24周龄组叶间动脉、弓形动脉、小叶间动脉平滑肌细胞中磷酸化ERK1/2明显增加,阳性率显著高于对照组(P<0.05)。结论:自发性高血压大鼠在16周龄以后出现少数肾小动脉血管的重构改变,可能与ERK1/2磷酸化导致的级联改变有关。
出处 《陕西医学杂志》 CAS 2011年第4期404-407,458,共5页 Shaanxi Medical Journal
基金 国家自然科学基金(30860095) 宁夏医科大学"博士学位建设学科"开放课题资助
  • 相关文献

参考文献9

  • 1Arribas SM, Hinek A, Gonzalez MC. Elastic fibres and vascular structure in hypertension[J]. Pharmacol Ther, 2006,111(3) :771.
  • 2王力宁 姚丽.高血压性肾损害.中华肾脏病杂志,2004,20(4):260-263.
  • 3Mulvany MJ. Small artery remodeling in hypertension [J].Curr Hypert Rep, 2002, 4(1):49-55.
  • 4Cruzado MC, Risler NR, Miatello RM,et al. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin Ⅱ and role of insulinlike growth factor-1 receptor transactivation [J]. Am J Hypertens, 2005,18(1) :81.
  • 5Jing L, Zhang JZ, Zhao L, et al. High-expression of transforming growth factor β1 and phosphorylation of extracellular signal-regulated protein kinase in vascular smooth muscle cells from aorta and renal arterioles of spontaneous hypertension rats[J]. Clin Clin Hyperten, 2007,29(2) :107-117.
  • 6Shukla N, Rowe D, Hinton J. Calcium and the replication of human vascular smooth muscle cells: studies on the activation and translocation of extracellular signal regulated kinase(ERK) and cyclin D1 expression[J]. Eur J Pharmacol, 2005, 509(1):21-30.
  • 7Skov K, Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension[J]. Acta Physiol Scand,2004, 181 (4) : 397-405.
  • 8张晓玲,薛冰,李莉,陈融,张永欢,李瑞峰,胡维诚.半边莲生物碱缓解肾性高血压大鼠的血管重塑[J].中国病理生理杂志,2008,24(6):1074-1077. 被引量:10
  • 9Touyz RM, Yao G, Schiffrin EL. Role of the aetin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells [ J ]. Can J Physiol Pharmacol, 2005,83(1) :91-97.

二级参考文献12

  • 1王婧婧,范秀珍,刘尚明,任冬梅,陈融,李莉,胡维诚.半边莲生物碱抑制内皮素-1诱导的人脐动脉平滑肌细胞增殖[J].中国病理生理杂志,2006,22(1):26-30. 被引量:7
  • 2王婧婧,范秀珍,刘尚明,魏欣冰,任冬梅,陈融,李莉,胡维诚.半边莲生物碱抑制内皮素诱导的大鼠主动脉平滑肌细胞增殖[J].中国动脉硬化杂志,2006,14(2):107-110. 被引量:7
  • 3Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension [ J]. J Am Coil Cardiol, 2004, 43( 12 Suppl S) : 13 -24.
  • 4Kett MM, Denton KM, Boesen El, et al. Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing [ J ]. Am J Hypertens, 2004, 17(2) : 161 - 166.
  • 5Sigmon DH, Beierwaltes WH. Endothelium derived constricting factor in renovascular hypertension [ J]. Hypertension, 1995, 25(4 Pt 2) :803 -808.
  • 6Porteri E, Rizzoni D, Castellano M, et al. Structural changes of small resistance arteries in spontaneously hypertensive rats after treatment with various doses of lacidipine [J]. J Hypertens, 1997,15(6) :619 -625.
  • 7Mulvany MJ. Small artery remodeling in hypertension [J]. Curt Hypert Rep, 2002,4(1) :49 -55.
  • 8Gao DF, Niu XL, Hao GH, et al. Rosiglitazone inhibits angiotensin Ⅱ - induced CTGF expression in vascular smooth muscle cells - role of PPAR - gamma in vascular fibrosis. [ J ]. Biochem Pharmacol, 2007, 73 (2) : 185 - 197.
  • 9Miner EC, Miller WL. A look between the cardiomyocytes: The extracellular matrix in heart failure [ J ]. Mayo Clin Proc, 2006, 81 ( 1 ) :71 - 76.
  • 10Motte S, McEntee K, Naeije R. Endothelin receptor antagonists [J]. Pharmacol Ther, 2006, 110 (3) :386 - 414.

共引文献11

同被引文献27

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部